CompletedNot Applicable

Effects of Wet Cupping Therapy in Patients With Asthma

Turkey (Türkiye)52 participantsStarted 2025-05-19

Plain-language summary

This study evaluated the effects of wet cupping therapy on immune modulation, pulmonary function, and quality of life in adults with asthma. A total of 52 participants aged 30 to 55 years were allocated to either a control group or a wet cupping therapy group. Participants in the wet cupping therapy group received two sessions of wet cupping therapy, at baseline and one month later. Participants in both groups underwent clinical assessments at baseline and at two months. Pulmonary function, asthma-related quality of life, asthma control, dyspnea, fatigue, anxiety, and depression were assessed in both groups. Selected inflammatory markers were assessed only in the wet cupping therapy group.

Who can participate

Age range

30 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:- * Adults aged 30 to 55 years. * Clinically diagnosed with asthma. * Asthma diagnosis established at least 6 months before enrollment. * No wet cupping therapy within the previous 2 months. * No herbal supplementation affecting asthma within the previous 2 months. * Able to cooperate with spirometry testing. Exclusion Criteria: * Presence of another chronic disease. * Hospitalization during the study period.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in FVC From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in Asthma Quality of Life Questionnaire Score From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in COPD and Asthma Fatigue Scale Score From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in FEV1 From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in FEV1/FVC Ratio From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in PEF From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in Systemic Immune-Inflammation Index (SII) in the Wet Cupping Therapy Group From Baseline to 2 Months

Timeframe: Baseline and 2 months

Trial details

NCT IDNCT07764042

SponsorMedipol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-13

View on ClinicalTrials.gov More Asthma (Diagnosis) trials

Plain-language summary

Who can participate

Age range

30 Years – 55 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Change in FVC From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in Asthma Quality of Life Questionnaire Score From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in COPD and Asthma Fatigue Scale Score From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in FEV1 From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in FEV1/FVC Ratio From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in PEF From Baseline to 2 Months

Timeframe: Baseline and 2 months

Change in Systemic Immune-Inflammation Index (SII) in the Wet Cupping Therapy Group From Baseline to 2 Months

Timeframe: Baseline and 2 months